About 2,938 results

ALLMedicine™ Lung Tumors Center

Research & Reviews  1,069 results

Artificial neural network in the discrimination of lung cancer based on infrared spectr...
PloS One; Lugtu EJ, Ramos DB et. al.

May 14th, 2022 - Given the increasing prevalence of lung cancer worldwide, an auxiliary diagnostic method is needed alongside the microscopic examination of biopsy samples, which is dependent on the skills and experience of pathologists. Thus, this study aimed to ...

Genomic landscape of chemical-induced lung tumors under Nrf2 different expression levels.
Carcinogenesis Satoh H, Arai Y et. al.

May 14th, 2022 - The transcription factor Nrf2 plays a crucial role in the anti-oxidative stress response, protection of DNA from injury, and DNA repair mechanisms. Nrf2 activity reduces cancer initiation, but how Nrf2 affects whole-genome alterations upon carcino...

Primary Alveolar Soft-Part Sarcoma of the Lung: A Case Report.
International Journal of Surgical Pathology; Zhao J, Peng J et. al.

May 7th, 2022 - Alveolar soft-part sarcoma is a rare type of soft tissue malignant tumor. Although the tumor can occur in many parts of the body, primary alveolar soft-part sarcoma of the lung is extremely rare. According to previous literature, only 3 cases of p...

Multi-institutional phase II study on the safety and efficacy of dynamic tumor tracking...
Radiotherapy and Oncology : Journal of the European Socie... Matsuo Y, Hiraoka M et. al.

May 6th, 2022 - This study aimed to evaluate the safety and efficacy of dynamic tumor tracking-stereotactic body radiotherapy (DTT-SBRT) for lung tumors. Patients with cStage I primary lung cancer or metastatic lung cancer with an expected range of respiratory mo...

Implications and efficacy of aromatase inhibitors in combination and monotherapy for th...
Anti-cancer Agents in Medicinal Chemistry; Rahal BA, Bardaweel SK

Apr 28th, 2022 - Lung tumors express high levels of aromatase enzyme compared to surrounding normal tissue. Inhibition of aromatase has emerged as a recent therapeutic approach for the treatment of breast cancer. However, the role of aromatase inhibition in lung c...

see more →

Drugs  8 results see all →

Clinicaltrials.gov  37 results

A Study of 99mTc-3PRGD2 Injection in Lung Cancer Patient

Apr 27th, 2022 - This study strictly obeyed to the result by pathological diagnoses standard. The evaluation of the efficacy of 99mTc-3PRGD2 in the diagnosis of lymph node metastasis of lung tumors is based on a multi-center, open, self-controlled clinical trial. ...

Chemoembolization for Lung Tumors

Apr 22nd, 2022 - This study is being done to determine if it is safe to perform lung chemoembolization and if the lung chemoembolization procedure can successfully deliver chemotherapy to lung tumors.

A Clinical Test for the Treatment of Multifocal Lung Cancers Using Genome Sequencing

Apr 14th, 2022 - A frequent clinical dilemma in lung cancer care is the management of multifocal lung cancers. The management decision is based on determining if multiple cancers represent true independent primary cancers or related metastasis. This determination ...

Bronchoscopic Laser Ablation of Peripheral Lung Tumors

Feb 16th, 2022 - PRIMARY OBJECTIVES: I. To assess the pathologic changes that result from bronchoscopic laser ablation of peripheral lung tumors focusing on the proportion of complete tumor ablation. SECONDARY OBJECTIVES: I. To assess the safety of this technique ...

Phase II Randomized Trial of Carboplatin+Pemetrexed+Bevacizumab+/- Atezolizumab in Stage IV NSCLC

Feb 10th, 2022 - While cigarette smoking remains the primary cause of most lung cancer cases, lung carcinoma in never smokers account for nearly 20 percent of cases. Never smokers with lung cancer typically present with different molecular profiles from that of sm...

see more →

News  60 results

Novel CRISPR Imaging Technology Reveals Genes Controlling Tumor Immunity

Mar 30th, 2022 - Mount Sinai scientists have developed a new technology allowing them to link specific genes to complex tumor characteristics at a scale and resolution not previously possible. The results could lead to new approaches for targeting anti-cancer drug...

Esophagus-Sparing Radiation Fails QOL Test in Lung Cancer

Feb 24th, 2022 - Esophageal-sparing intensity-modulated radiotherapy (ES-IMRT) failed to improve esophageal quality of life, but did significantly reduce the incidence of symptomatic esophagitis, in patients with advanced non-small cell lung cancer (NSCLC), accord...

Tissue Truly Is the Issue in Advanced Non-Small Cell Lung Cancer

Oct 6th, 2021 - Jimmy Ruiz, MD Assistant Professor of Medicine, Hematology and Oncology Assistant Director of Cancer Health Equity Wake Forest Baptist Medical Center — Comprehensive Cancer Center Non-small cell lung cancer (NSCLC) is no longer...

Cryoablation May Offer Option for Metastatic Lung Tumors

Oct 6th, 2021 - David A. Woodrum, MD, PhD The results of the first prospective multicenter trial of cryoablation in lung cancer show that this emerging treatment may be a safe, effective, and minimally invasive method of helping a specific group of patients with...

Roswell Park Is First Center in New York State to Implement Monarch Bronchoscopy Platform

Oct 6th, 2021 - Lung specialists at Roswell Park Comprehensive Cancer Center now have a tool for visualizing and reaching lung nodules through a minimally invasive approach, enabling earlier diagnosis of cancer, smaller biopsies and broader treatment options for ...

see more →

Patient Education  1 results see all →